HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 22 filers reported holding HEMISPHERX BIOPHARMA INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $103,000 | -13.4% | 897,977 | 0.0% | 0.00% | – |
| Q1 2016 | $119,000 | +65.3% | 897,977 | 0.0% | 0.00% | – |
| Q4 2015 | $72,000 | -52.9% | 897,977 | 0.0% | 0.00% | – |
| Q3 2015 | $153,000 | -16.4% | 897,977 | 0.0% | 0.00% | – |
| Q2 2015 | $183,000 | -10.3% | 897,977 | 0.0% | 0.00% | – |
| Q1 2015 | $204,000 | -8.9% | 897,977 | 0.0% | 0.00% | – |
| Q4 2014 | $224,000 | -22.2% | 897,977 | 0.0% | 0.00% | – |
| Q3 2014 | $288,000 | +20.0% | 897,977 | +15.6% | 0.00% | – |
| Q2 2014 | $240,000 | -22.6% | 777,066 | 0.0% | 0.00% | – |
| Q1 2014 | $310,000 | +108.1% | 777,066 | +37.7% | 0.00% | – |
| Q4 2013 | $149,000 | +12.0% | 564,507 | 0.0% | 0.00% | – |
| Q3 2013 | $133,000 | +5.6% | 564,507 | 0.0% | 0.00% | – |
| Q2 2013 | $126,000 | – | 564,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Occidental Asset Management, LLC | 190,000 | $570,000 | 0.87% |
| FutureAdvisor, Inc. | 6,606 | $323,000 | 0.11% |
| WEDBUSH SECURITIES INC | 75,000 | $19,000 | 0.00% |
| Virtu KCG Holdings LLC | 330,323 | $83,000 | 0.00% |
| Joel Isaacson & Co., LLC | 15,500 | $4,000 | 0.00% |
| CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 104,750 | $26,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 10,396 | $3,000 | 0.00% |
| NORTHERN TRUST CORP | 236,866 | $59,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $224,000 | 0.00% |